The U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) have updated their clinical practice guidelines for the management of headache to include several treatments recently approved by the U.S. Food and Drug Administration (FDA).
Tag: Migraine
New Study: Drug May Stop Migraines Before Headache Starts
When taken at the first signs of a migraine, before headache pain begins, a drug called ubrogepant may be effective in helping people with migraine go about their daily lives with little or no symptoms, according to a new study published in the August 28, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Are Cardiovascular Risk Factors Linked to Migraine?
Having high blood pressure, specifically high diastolic blood pressure, was linked to a slightly higher odds of ever having migraine in female participants, according to a new study published in the July 31, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. Diastolic pressure is when the heart is resting between beats.
NIH Awards Wake Forest University School of Medicine $3.2 Million to Study Non-Opioid Migraine Treatments
Researchers at Wake Forest University School of Medicine have received a five-year, $3.2 million grant from the National Center for Complementary and Integrative Health, part of the National Institutes of Health (NIH), to study the effectiveness of non-pharmacological treatments for migraine.
Could Preventative Drug Be Effective in People with Migraine and Rebound Headache?
A drug used to prevent migraine may also be effective in people with migraine who experience rebound headaches, according to a new study published in the June 26, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Use of Acid Reflux Drugs Linked to Higher Risk of Migraine
People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology® Clinical Practice, an official journal of the American Academy of Neurology. The acid-reducing drugs include proton pump inhibitors such as omeprazole and esomeprazole, histamine H2-receptor antagonists, or H2 blockers, such as cimetidine and famotidine, and antacid supplements.
Menopause and migraines: New findings point to power of prevention
Women who have both migraines and a long-term history of hot flashes and/or night sweats have a slightly higher risk of heart disease and stroke, and young women who have migraines have a higher risk of later persistent menopause symptoms, according to a new pair of papers.
Long COVID-19 is linked to chronic pain conditions
Therapies for pain conditions like fibromyalgia provide clues for helping those with long COVID, finds a new University of Michigan study.
THE GORE RELIEF CLINICAL STUDY BEGINS RANDOMIZING PATIENTS TO EVALUATE PFO CLOSURE FOR MIGRAINE HEADACHE RELIEF
The Gore RELIEF Clinical Study is evaluating the safety and efficacy of transcatheter closure of patent foramen ovale (PFO) with the GORE® CARDIOFORM Septal Occluder for the relief of migraine headaches.
Reduced frequency & intensity of migraine attacks after single dose of psilocybin
Psilocybin – the active ingredient in psychedelic mushrooms – shows promise for the transitional treatment of episodic migraines in early clinical trials, according to a review from Yale School of Medicine’s Emmanuelle Schindler, M.D., Ph.D. In the first and only…
Injection of Hope: How Botox Keeps Migraines at Bay
Dr. Santiago Mazuera, head of Sinai Hospital’s Headache Clinic, shares how Botox treatments can drastically improve quality of life for those who experience chronic migraines.
CEFALY Technology Presents TEAM Study Findings at the American Headache Society’s 2023 Scientific Meeting
Medical device maker CEFALY Technology announced that two post-hoc analyses of the TEAM (a phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine) study were presented as posters at the American Headache Society’s 65th Annual Scientific Meeting June 15-18 in Austin, Texas.
Promising new tool for treating migraine headaches — expert available
If you don’t suffer from migraine headaches yourself, chances are you know someone who does. These debilitating headaches commonly effect women between the ages of 25 and 55, and can be known to cause several other symptoms such as nausea…
Low Estrogen Levels Paired with Higher CGRP Levels May Jump Start Migraine
As estrogen levels fluctuate, a new study has found for female participants with migraine, their levels of the protein calcitonin gene-related peptide (CGRP) that plays a key role in starting the migraine process also fluctuate. The study is published in the February 22, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.
CEFALY Technology Introduces Bluetooth-Enabled CEFALY Connected Migraine Treatment Device
Medical device maker CEFALY Technology today unveiled the newest evolution of its FDA-cleared migraine treatment device: the CEFALY Connected.
CEFALY Technology Marks a Milestone: 2 Billion Migraines Treated & Counting!
As Migraine and Headache Awareness Month kicks off, CEFALY Technology is celebrating its 8th anniversary in the United States and a major milestone: 2 billion migraines treated with the CEFALY migraine treatment device.
A Painless, Micro Injection that You Can Do Yourself with the Latest Chula’s Innovation “Detachable and Dissolvable Microneedles”
A startup under the umbrella of CU Innovation Hub in collaboration with the Chula Faculty of Science has developed an innovative “Detachable and Dissolvable Microneedle” that makes any injections easy and painless for everyone, while also significantly reducing medical wastes.
How Do Migraines Affect the Sleep Cycle?
Adults and children with migraines may get less quality, REM sleep time than people who don’t have migraines. That’s according to a meta-analysis published in the September 22, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. Children with migraines were also found to get less total sleep time than their healthy peers but took less time to fall asleep.
How migraines protect against diabetes
People who get migraines are less likely to develop type 2 diabetes. Today, scientists report the latest findings about the relationship between insulin production and the peptides that cause migraine pain. They will present their results at ACS Fall 2021.
What Does a Virtual Roller Coaster Ride Tell Us About Migraine?
When experiencing the ups and downs of a virtual roller coaster ride, people who get migraine headaches reported more dizziness and motion sickness than people who do not get migraines, according to a new study published in the July 7, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Changing Consumption of Certain Fatty Acids Can Lessen Severity of Headaches
Migraine is one of the largest causes of disability in the world. Existing treatments are often not enough to offer full relief for patients. A new study published in The BMJ demonstrates an additional option patients can use in their effort to experience fewer migraines and headaches – a change in diet.
UIC researcher finds possible novel migraine therapy
By discovering a potential new cellular mechanism for migraines, researchers may have also found a new way to treat chronic migraine. Amynah Pradhan, associate professor of psychiatry at the University of Illinois Chicago, is the senior author of the study, whose goal was to identify a new mechanism of chronic migraine, and propose a cellular pathway for migraine therapies.
Peter Goadsby, migraine expert, awarded the Brain Prize 2021
Dr. Peter Goadsby, professor of neurology at the David Geffen School of Medicine at UCLA, has been chosen as one of four recipients of the Brain Prize 2021. The prize honors scientists who have made outstanding contributions to the field of neuroscience. Dr. Goadsby will receive a personal prize of 2.5 million Danish kroner, or about $400,000.
Can Cannabis Use Lead to Rebound Headaches for People with Migraine?
Using cannabis for relief from migraine headache may be associated with developing “rebound” headache, or medication overuse headache, which occurs when pain medication is overused by patients who have an underlying primary headache disorder such as migraine, according to a preliminary study released today March 1, 2021, that will be presented at the American Academy of Neurology’s 73rd Annual Meeting being held virtually April 17 to 22, 2021.
Do People with Migraine Get Enough Exercise?
More than two-thirds of people with migraine do not get enough exercise, according to a preliminary study released today, February 23, 2021, that will be presented at the American Academy of Neurology’s 73rd Annual Meeting being held virtually April 17 to 22, 2021. The study found that people who do get a minimum of two-and-a-half hours of moderate to vigorous exercise a week had a reduced rate of migraine triggers like stress, depression and sleep problems.
Press and Media Registration is Open for 2021 AAN Annual Meeting
No matter where you are in the world, the 2021 AAN Annual Meeting is one click away. Journalists can now register to attend the 73rd Annual Meeting of the American Academy of Neurology (AAN) being held virtually April 17-22, 2021. The AAN Annual Meeting is the world’s largest gathering of neurologists who come together to share the latest advances in neurologic research.
Mindfulness Meditation May Decrease Impact of Migraine
In a recent clinical trial from Wake Forest Baptist Health, researchers showed that mindfulness-based stress reduction (MBSR) may provide benefit to people with migraine.
Unexpected Discovery Leads to Better Understanding of Migraine
Massive “plumes” of glutamate, a key neurotransmitter, surging in the brain could help explain the onset of migraine with aura—and potentially a broad swath of neurologic disease, including stroke and traumatic brain injury—according to an international study led by University of Utah Health scientists.
Can you paint your migraine?
“Can you draw me a picture of your headache?” may sound like an unusual question – but drawings of headache pain provide plastic surgeons with valuable information on which patients are more or less likely to benefit from surgery to alleviate migraine headaches.
For Better Migraine Treatment, Try Adding Some Downward Dogs
Adding yoga to your regularly prescribed migraine treatment may be better than medication alone, according to a study published in the May 6, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology. The new research suggests yoga may help people with migraines have headaches that happen less often, don’t last as long and are less painful. EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, MAY 6, 2020
Media Contacts:
Renee Tessman, [email protected], (612) 928-6137
M.A. Rosko, [email protected], (612) 928-6169
For Better Migraine Treatment, Try Adding Some Downward Dogs
MINNEAPOLIS – Adding yoga to your regularly prescribed migraine treatment may be better than medication alone, according to a study published in the May 6, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology. The new research suggests yoga may help people with migraines have headaches that happen less often, don’t last as long and are less pain
Mindfulness an Effective Treatment for Migraines
In an article published March 13, 2020 in the journal Pain, David A. Seminowicz, PhD, associate professor in the Department of Neural and Pain Sciences at the University of Maryland School of Dentistry, and coauthors show how mindfulness can help in the fight against migraines.
The Medical Minute: New treatments for migraines show promise
Many people think migraines are just bad headaches – but they’re so much more. While no cure for migraines exists, hope abounds thanks to major advances in research.